Font Size: a A A
Keyword [Unfractionated heparin]
Result: 1 - 20 | Page: 1 of 3
1. Iontophoretic Transmucosal Delivery Of Unfractionated And Low Molecular Weight Heparins
2. Aspirin Enhance ADP-induced Platelet Aggregation By Unfractionated Heparin And The Possible Mechanisms
3. The Influencing Factors Of Inpatient Mortality Of Acute Myocardial Infarction And Reperfusion Therapy Prospective Comparative Study
4. Effects Of Low Molecular Weight Heparin And Unfractionated Heparin On VWF,D-dm And CD62P In Patients With Unstable Angina
5. Comparison Of Unfractionated Heparin And Low-molecular-weight-heparin In Treating Patients With PTE
6. A Randomized Comparative Study Of The Effects Of Low Molecular Weight Heparin (Fragmin) Or Unfractionated Heparin On Plasma Anti-Xa Activity And Activated Clotting Time During Elective Percutaneous Coronary Intervention
7. Comparison Of Intravenous Enoxaparin Versus Unfractionated Heparin During Elective Percutaneous Coronary Intervention
8. Inhibition Of Aspirin And Clopidogrel On Platelet Activion Of Rabbit Induced By Unfractionated Heparin
9. Possible Effects Of Plasma Troponin I, Creatine Kinase MB And Myoglobin Using Fragmin And Unfractionated Heparin In Elective Percutaneous Coronary Intervention
10. Clinical Research On Activation Of Platelet And Prothrombin After Transcatheter Closure Of Atrial Septal Defects
11. The Influence Of Unfractionated Heparin, Dalteparin And Enoxaparin On Platelet Activation During Coronary Angioagraphy
12. Effects Of Heparin On Hepatic Regeneration After 50% Partial Liver Transplantation In Rats
13. The Effect Of The Intervention With Unfractionated Heparin (UFH) Or Low Molecular Weight Heparin (LMWH) On Fluid-resuscitated Sepsis Rats
14. The Safety And Efficacy Of Enoxaparin In PCI For Patients With Non-ST Segment Elevated Myocardial Infarction
15. The Incidence Of Low Molecular Weight Heparin-induced Thrombocytopenia And Analysis Of Related Factors
16. Safety And Effectiveness Of Dalteparin Versus Unfractionated Heparin During Elective Percutaneous Coronary Interventions
17. Clinical Study Of Unfractionated Heparin In Prevention Of Coagulation Disorders In Infants With Placental Abruption
18. ACT Monitoring Anticoagulant Applications Of Patients With Coronary Heart Disease After Interventional Operation
19. Coagulation Invention Of The Postoperative Coagulation Bridging Period After Prosthetic Valve Implantation
20. Clinical Observation On The Safety And Therapeutic Effect Of Bivalirudin During PCI To Patients With ACS
  <<First  <Prev  Next>  Last>>  Jump to